Enabling the state of Uttar Pradesh with a modern high-tech lab, aiming to transform patient care ...
An aero-elastic sensor that revolutionises the way pressure is detected...
First microarray-based solution in Singapore to enable multi-gene panel testing for pharmacogenomics and disease risk assessment...
Company Adds Key Products to its Comprehensive Cervical Spine Portfolio...
GASTROClear is the first miRNA blood test and the first gastric cancer molecular test globally to receive FDA Breakthrough Device Designation...
To provide crucial information that could ultimately be used to improve treatments...
Announces AI-powered visual-to-text transformation pilot testing for dental X-rays, with Kindlehouse Dentistry partnership...
Yashoda Medicity, the upcoming healthcare facility by Yashoda Foundations in Indirapuram, is collaborating with Draeger India, a renowned global medical and safety technology solutions provider. Yashoda Medicity is the new addition to the renowned healthcare institution Yashoda Super Speciality Hospital, well acknowledged for its exceptional patient care and facilities. Together, Yashoda Medicity and Dräger are embarking on a groundbreaking initiative to establish one of the largest modular Int...
JelloX Biotech, a Taiwanese startup, is at the forefront of revolutionising cancer pathology by utilising 3D digital imaging and Artificial Intelligence (AI) technology. Its 3D imaging technology demonstrates potential beyond the field of oncology. In a groundbreaking paper published in February 2023, Dr Lin-Shien Fu and colleagues from Taiwan's Taichung Veterans General Hospital showcased the innovative application of their 3D pathology in analysing kidney inflammation caused by lupus nephritis...
Biomedicine is a top priority for Taiwan, with the government aiming to position the country as the leading hub for biomedical research and development in the Asia-Pacific region. By 2025, Taiwan aims to create 20 new medicines, introduce 80 high-value medical devices to the market, and elevate the biomedicine industry into a trillion-NT-dollar (approximately $32 billion) sector. The government has taken various initiatives, established biomedicines clusters and tweaked policies to achieve this ...
